日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma

突变的FGFR1是高危神经母细胞瘤的致癌驱动因素和治疗靶点。

Werr, Lisa; Boland, Jana; Petersen, Josephine; Iglesias, Fiorella; Höppner, Stefanie; Bartenhagen, Christoph; Rosswog, Carolina; Hellmann, Anna-Maria; Kahlert, Yvonne; Hemstedt, Nadine; Ibruli, Nadliv; Dammert, Marcel A; Decarolis, Boris; Werner, Jan-Michael; Malchers, Florian; Schramm, Kathrin; Witt, Olaf; Beiske, Klaus H; Rognlien, Anne Gro Wesenberg; Gunnes, Maria Winther; Langenberg, Karin P; Molenaar, Jan; Bernkopf, Marie; Taschner-Mandl, Sabine; Hughes, Debbie; George, Sally L; Chesler, Louis; Schulte, Johannes H; Barone, Giuseppe; Capasso, Mario; Surrey, Lea F; Bagatell, Rochelle; Masliah-Planchon, Julien; Schleiermacher, Gudrun; Grüll, Holger; Westermann, Frank; Schultheis, Anne M; Büttner, Reinhard; Henssen, Anton G; Eggert, Angelika; Peifer, Martin; Shukla, Neerav N; Simon, Thorsten; Hero, Barbara; Reinhardt, H Christian; Thomas, Roman K; Fischer, Matthias

Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children's Oncology Group

儿童肿瘤协作组的一份报告指出,不良组织学特征与临床M期相结合,可定义高危神经母细胞瘤。

Hazard, Florette K; Toland, Angus M S; Tan, Serena Y; Chiu, Bill; Ikegaki, Naohiko; Naranjo, Arlene; Cohn, Susan L; London, Wendy B; Gastier-Foster, Julie M; Ramirez, Nilsa C; Reshmi, Shalini C; Wagner, Elizabeth; Nuchtern, Jed; Asgharzadeh, Shahab; Marachelian, Araz; Maris, John M; Bagatell, Rochelle; Park, Julie R; Irwin, Meredith S; Hogarty, Michael D; Shimada, Hiroyuki

Collecting Social Determinants of Health in a Children's Oncology Group Trial for High-Risk Neuroblastoma

在儿童肿瘤协作组针对高危神经母细胞瘤的试验中收集健康社会决定因素

Jones, Emily; Naranjo, Arlene; Winestone, Lena E; Umaretiya, Puja J; Aziz-Bose, Rahela; Kelly, Colleen A; Newman, Haley; Zheng, Daniel J; Greengard, Emily; Bagatell, Rochelle; DuBois, Steven G; Bona, Kira

International neuroblastoma risk group consortium: a model of networking for rare cancers

国际神经母细胞瘤风险组联盟:罕见癌症网络模式

Cohn, Susan L; London, Wendy B; Schleiermacher, Gudrun; Moreno, Lucas; Ambros, Inge M; Ambros, Peter F; Bagatell, Rochelle; Popovic, Maja Beck; Beiske, Klaus Hermann; Berthold, Frank; Birz, Suzi; Brisse, Hervé J; Brodeur, Garrett M; Brock, Penelope R; Burchill, Susan; Eggert, Angelika; Federico, Sara M; Fischer, Matthias; Furner, Brian T; Hero, Barbara; Machin, David; Kamijo, Takehiko; Matthay, Katherine K; Nakagawara, Akira; Naranjo, Arlene; Pötschger, Ulrike; Valteau-Couanet, Dominique; Watkins, Michael T; Irwin, Meredith S; Volchenboum, Samuel L; Park, Julie R; Pearson, Andrew D J

Frequency and Clinical Significance of Clonal and Subclonal Driver Mutations in High-Risk Neuroblastoma at Diagnosis: A Children's Oncology Group Study

儿童肿瘤协作组研究:高危神经母细胞瘤诊断时克隆和亚克隆驱动基因突变的频率和临床意义

Berko, Esther R; Naranjo, Arlene; Daniels, Alexander A; McNulty, Samantha N; Krytska, Kateryna; Druley, Todd; Zelley, Kirstin; Koneru, Balakrishna; Chen, Lulu; Polkosnik, Grace; Irwin, Meredith S; Bagatell, Rochelle; Maris, John M; Reynolds, C Patrick; DuBois, Steven G; Park, Julie R; Mossé, Yael P

Chromosomal instability degrades developmental phenotypes essential for anti-GD2 immunotherapy outcomes in high-risk neuroblastoma

染色体不稳定性会降低高危神经母细胞瘤抗GD2免疫疗法疗效所必需的发育表型。

Rebernick, Ryan James; Choi, Jae Eun; Hesse, Calvin; Hosseini, Noshad; Chu, Alec; Zhou, Jin; Ning, Yu; Wang, Rui; Cao, Xuhong; Irwin, Meredith; Wu, Yi-Mi; Kumar, Chandan; Rabah, Raja; Bagatell, Rochelle; Chinnaiyan, Arul M; Mody, Rajen; Cieslik, Marcin

Racial and Ethnic Survival Disparities Among Children With High-Risk Neuroblastoma: A Children's Oncology Group Report

儿童肿瘤协作组关于高危神经母细胞瘤患儿种族和民族生存差异的报告

Umaretiya, Puja J; Naranjo, Arlene; Zhang, Fan F; Park, Julie R; Weiss, Brian D; Granger, Meaghan; Desai, Ami V; Ozkaynak, M Fevzi; Yu, Alice L; Aziz-Bose, Rahela; Pruitt, Sandi L; DuBois, Steven G; Bagatell, Rochelle; Bona, Kira

Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531

影像定义风险因素(IDRF)评估在中危神经母细胞瘤患者中的应用:来自儿童肿瘤协作组研究 ANBL0531 的报告

Brown, Erin G; Adkins, E Stanton; Mattei, Peter; Hoffer, Fredric A; Wootton-Gorges, Sandra L; London, Wendy B; Naranjo, Arlene; Schmidt, Mary L; Hogarty, Michael D; Irwin, Meredith S; Cohn, Susan L; Park, Julie R; Maris, John M; Bagatell, Rochelle; Twist, Clare J; Nuchtern, Jed G; Davidoff, Andrew M; Newman, Erika A; Lal, Dave R

Long-Term Outcome of Young Infants With Suspected Neuroblastoma following Observation as Primary Therapy: A Report From the Children's Oncology Group

儿童肿瘤协作组关于以观察作为主要治疗手段治疗疑似神经母细胞瘤婴幼儿的长期预后报告

Dholaria, Hetal; Naranjo, Arlene; Zhang, Fan F; London, Wendy B; Diller, Lisa; Shamberger, Robert C; Barnewolt, Carol E; Schmidt, Mary Lou; Maris, John M; Cohn, Sue L; Bagatell, Rochelle; Nuchtern, Jed G

Outcomes of patients with intermediate-risk neuroblastoma presenting with motor deficits relating to intraspinal tumor extension: A report from the Children's Oncology Group study ANBL0531

儿童肿瘤协作组研究 ANBL0531 报告:伴有脊髓内肿瘤扩散相关运动功能障碍的中危神经母细胞瘤患者的预后

Voeller, Julie; Katzenstein, Howard M; Naranjo, Arlene; Tenney, Sheena C; Chen, Lulu; London, Wendy B; Handler, Michael H; Schmidt, Mary Lou; Shimada, Hiroyuki; Hogarty, Michael D; Gastier-Foster, Julie; Park, Julie R; Cohn, Susan L; Maris, John M; Bagatell, Rochelle; Twist, Clare J